Industry: Healthcare
Published Date: February-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 234
Report ID: PMRREP34004
1. Executive Summary
1.1. Global Onychomycosis Treatment Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Treatment Type Lifecycle Analysis
2.4. Onychomycosis Treatment Market: Value Chain
2.4.1. List of Raw Material Supplier
2.4.2. List of Manufacturers
2.4.3. List of Distributors
2.4.4. List of Applications
2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
2.7.1. Global Sectorial Outlook
2.7.2. Global GDP Growth Outlook
2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape
3. Global Onychomycosis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
3.1. Key Highlights
3.1.1. Market Volume (Units) Projections
3.1.2. Market Size and Y-o-Y Growth
3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
3.2.1. Historical Market Size Analysis, 2013-2016
3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global Onychomycosis Treatment Market Outlook: Treatment Type
3.3.1. Introduction / Key Findings
3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Treatment Type, 2018 - 2022
3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
3.3.3.1. Drugs
3.3.3.1.1. Oral
3.3.3.1.2. Rx
3.3.3.1.3. OTC
3.3.3.1.4. Topical
3.3.3.1.5. Rx
3.3.3.1.6. OTC
3.3.3.2. Lasers
3.3.3.2.1. C02 Ablative Lasers
3.3.3.2.2. Nd: YAG Lasers
3.3.3.2.3. Dual-wavelength near-infrared Lasers
3.3.3.3. Photodynamic Therapy
3.4. Market Attractiveness Analysis: Treatment Type
3.5. Global Onychomycosis Treatment Market Outlook: Disease Indication
3.5.1. Introduction / Key Findings
3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Disease Indication, 2018 - 2022
3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease Indication, 2023 - 2030
3.5.3.1. Distal Subungual Onychomycosis
3.5.3.2. White Superficial Onychomycosis
3.5.3.3. Proximal Subungual Onychomycosis
3.5.3.4. Candidal Onychomycosis
3.5.3.5. Total Dystrophic Onychomycosis
3.6. Market Attractiveness Analysis: Disease Indication
3.7. Global Onychomycosis Treatment Market Outlook: Age Group
3.7.1. Introduction / Key Findings
3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Age Group, 2018 - 2022
3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
3.7.3.1. 0 to 18 Years
3.7.3.2. 18 to 39 Years
3.7.3.3. 40 to 64 Years
3.7.3.4. 65 Years & Above
3.8. Market Attractiveness Analysis: Age Group
3.9. Global Onychomycosis Treatment Market Outlook: Distribution Channel
3.9.1. Introduction / Key Findings
3.9.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Distribution Channel, 2018 - 2022
3.9.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
3.9.3.1. Institutional Sales
3.9.3.2. Hospitals
3.9.3.3. Dermatology Clinics
3.9.3.4. Retail Sales
3.9.3.5. Retail Pharmacies
3.9.3.6. Drug Stores
3.9.3.7. Mail Order Pharmacies & Online Sales
3.10. Market Attractiveness Analysis: Distribution Channel
4. Global Onychomycosis Treatment Market Outlook: Region
4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
4.3.1. North America
4.3.2. Europe
4.3.3. East Asia
4.3.4. South Asia and Oceania
4.3.5. Latin America
4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region
5. North America Onychomycosis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
5.3.1. By Country
5.3.2. By Treatment Type
5.3.3. By Disease Indication
5.3.4. By Age Group
5.3.5. By Distribution Channel
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
5.4.1. U.S.
5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
5.5.1. Drugs
5.5.1.1. Oral
5.5.1.2. Rx
5.5.1.3. OTC
5.5.1.4. Topical
5.5.1.5. Rx
5.5.1.6. OTC
5.5.2. Lasers
5.5.2.1. C02 Ablative Lasers
5.5.2.2. Nd: YAG Lasers
5.5.2.3. Dual-wavelength near-infrared Lasers
5.5.3. Photodynamic Therapy
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease Indication, 2023 - 2030
5.6.1. Distal Subungual Onychomycosis
5.6.2. White Superficial Onychomycosis
5.6.3. Proximal Subungual Onychomycosis
5.6.4. Candidal Onychomycosis
5.6.5. Total Dystrophic Onychomycosis
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
5.7.1. 0 to 18 Years
5.7.2. 18 to 39 Years
5.7.3. 40 to 64 Years
5.7.4. 65 Years & Above
5.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
5.8.1. Institutional Sales
5.8.2. Hospitals
5.8.3. Dermatology Clinics
5.8.4. Retail Sales
5.8.5. Retail Pharmacies
5.8.6. Drug Stores
5.8.7. Mail Order Pharmacies & Online Sales
5.9. Market Attractiveness Analysis
6. Europe Onychomycosis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
6.3.1. By Country
6.3.2. By Treatment Type
6.3.3. By Disease Indication
6.3.4. By Age Group
6.3.5. By Distribution Channel
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
6.4.1. Germany
6.4.2. France
6.4.3. U.K.
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Türkiye
6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
6.5.1. Drugs
6.5.1.1. Oral
6.5.1.2. Rx
6.5.1.3. OTC
6.5.1.4. Topical
6.5.1.5. Rx
6.5.1.6. OTC
6.5.2. Lasers
6.5.2.1. C02 Ablative Lasers
6.5.2.2. Nd: YAG Lasers
6.5.2.3. Dual-wavelength near-infrared Lasers
6.5.3. Photodynamic Therapy
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease Indication, 2023 - 2030
6.6.1. Distal Subungual Onychomycosis
6.6.2. White Superficial Onychomycosis
6.6.3. Proximal Subungual Onychomycosis
6.6.4. Candidal Onychomycosis
6.6.5. Total Dystrophic Onychomycosis
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
6.7.1. 0 to 18 Years
6.7.2. 18 to 39 Years
6.7.3. 40 to 64 Years
6.7.4. 65 Years & Above
6.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
6.8.1. Institutional Sales
6.8.2. Hospitals
6.8.3. Dermatology Clinics
6.8.4. Retail Sales
6.8.5. Retail Pharmacies
6.8.6. Drug Stores
6.8.7. Mail Order Pharmacies & Online Sales
6.9. Market Attractiveness Analysis
7. East Asia Onychomycosis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
7.3.1. By Country
7.3.2. By Treatment Type
7.3.3. By Disease Indication
7.3.4. By Age Group
7.3.5. By Distribution Channel
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
7.4.1. China
7.4.2. Japan
7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
7.5.1. Drugs
7.5.1.1. Oral
7.5.1.2. Rx
7.5.1.3. OTC
7.5.1.4. Topical
7.5.1.5. Rx
7.5.1.6. OTC
7.5.2. Lasers
7.5.2.1. C02 Ablative Lasers
7.5.2.2. Nd: YAG Lasers
7.5.2.3. Dual-wavelength near-infrared Lasers
7.5.3. Photodynamic Therapy
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease Indication, 2023 - 2030
7.6.1. Distal Subungual Onychomycosis
7.6.2. White Superficial Onychomycosis
7.6.3. Proximal Subungual Onychomycosis
7.6.4. Candidal Onychomycosis
7.6.5. Total Dystrophic Onychomycosis
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
7.7.1. 0 to 18 Years
7.7.2. 18 to 39 Years
7.7.3. 40 to 64 Years
7.7.4. 65 Years & Above
7.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
7.8.1. Institutional Sales
7.8.2. Hospitals
7.8.3. Dermatology Clinics
7.8.4. Retail Sales
7.8.5. Retail Pharmacies
7.8.6. Drug Stores
7.8.7. Mail Order Pharmacies & Online Sales
7.9. Market Attractiveness Analysis
8. South Asia & Oceania Onychomycosis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
8.3.1. By Country
8.3.2. By Treatment Type
8.3.3. By Disease Indication
8.3.4. By Age Group
8.3.5. By Distribution Channel
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
8.4.1. India
8.4.2. Southeast Asia
8.4.3. ANZ
8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
8.5.1. Drugs
8.5.1.1. Oral
8.5.1.2. Rx
8.5.1.3. OTC
8.5.1.4. Topical
8.5.1.5. Rx
8.5.1.6. OTC
8.5.2. Lasers
8.5.2.1. C02 Ablative Lasers
8.5.2.2. Nd: YAG Lasers
8.5.2.3. Dual-wavelength near-infrared Lasers
8.5.3. Photodynamic Therapy
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease Indication, 2023 - 2030
8.6.1. Distal Subungual Onychomycosis
8.6.2. White Superficial Onychomycosis
8.6.3. Proximal Subungual Onychomycosis
8.6.4. Candidal Onychomycosis
8.6.5. Total Dystrophic Onychomycosis
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
8.7.1. 0 to 18 Years
8.7.2. 18 to 39 Years
8.7.3. 40 to 64 Years
8.7.4. 65 Years & Above
8.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
8.8.1. Institutional Sales
8.8.2. Hospitals
8.8.3. Dermatology Clinics
8.8.4. Retail Sales
8.8.5. Retail Pharmacies
8.8.6. Drug Stores
8.8.7. Mail Order Pharmacies & Online Sales
8.9. Market Attractiveness Analysis
9. Latin America Onychomycosis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
9.3.1. By Country
9.3.2. By Treatment Type
9.3.3. By Disease Indication
9.3.4. By Age Group
9.3.5. By Distribution Channel
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
9.5.1. Drugs
9.5.1.1. Oral
9.5.1.2. Rx
9.5.1.3. OTC
9.5.1.4. Topical
9.5.1.5. Rx
9.5.1.6. OTC
9.5.2. Lasers
9.5.2.1. C02 Ablative Lasers
9.5.2.2. Nd: YAG Lasers
9.5.2.3. Dual-wavelength near-infrared Lasers
9.5.3. Photodynamic Therapy
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease Indication, 2023 - 2030
9.6.1. Distal Subungual Onychomycosis
9.6.2. White Superficial Onychomycosis
9.6.3. Proximal Subungual Onychomycosis
9.6.4. Candidal Onychomycosis
9.6.5. Total Dystrophic Onychomycosis
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
9.7.1. 0 to 18 Years
9.7.2. 18 to 39 Years
9.7.3. 40 to 64 Years
9.7.4. 65 Years & Above
9.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
9.8.1. Institutional Sales
9.8.2. Hospitals
9.8.3. Dermatology Clinics
9.8.4. Retail Sales
9.8.5. Retail Pharmacies
9.8.6. Drug Stores
9.8.7. Mail Order Pharmacies & Online Sales
9.9. Market Attractiveness Analysis
10. Middle East & Africa Onychomycosis Treatment Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)
10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
10.3.1. By Country
10.3.2. By Treatment Type
10.3.3. By Disease Indication
10.3.4. By Age Group
10.3.5. By Distribution Channel
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
10.4.1. GCC
10.4.2. Egypt
10.4.3. South Africa
10.4.4. Northern Africa
10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Treatment Type, 2023 - 2030
10.5.1. Drugs
10.5.1.1. Oral
10.5.1.2. Rx
10.5.1.3. OTC
10.5.1.4. Topical
10.5.1.5. Rx
10.5.1.6. OTC
10.5.2. Lasers
10.5.2.1. C02 Ablative Lasers
10.5.2.2. Nd: YAG Lasers
10.5.2.3. Dual-wavelength near-infrared Lasers
10.5.3. Photodynamic Therapy
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Disease Indication, 2023 - 2030
10.6.1. Distal Subungual Onychomycosis
10.6.2. White Superficial Onychomycosis
10.6.3. Proximal Subungual Onychomycosis
10.6.4. Candidal Onychomycosis
10.6.5. Total Dystrophic Onychomycosis
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Age Group, 2023 - 2030
10.7.1. 0 to 18 Years
10.7.2. 18 to 39 Years
10.7.3. 40 to 64 Years
10.7.4. 65 Years & Above
10.8. Current Market Size (US$ Mn) and Volume (Units) Forecast By Distribution Channel, 2023 - 2030
10.8.1. Institutional Sales
10.8.2. Hospitals
10.8.3. Dermatology Clinics
10.8.4. Retail Sales
10.8.5. Retail Pharmacies
10.8.6. Drug Stores
10.8.7. Mail Order Pharmacies & Online Sales
10.9. Market Attractiveness Analysis
11. Competition Landscape
11.1. Market Share Analysis, 2022
11.2. Market Structure
11.2.1. Competition Intensity Mapping By Market
11.2.2. Competition C02 Ablative Lasers
11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
11.3.1. Teva Pharmaceutical Industries Ltd.
11.3.1.1. Overview
11.3.1.2. Segments and Product
11.3.1.3. Key Financials
11.3.1.4. Market Developments
11.3.1.5. Market Strategy
11.3.2. Sanofi S.A.
11.3.2.1. Overview
11.3.2.2. Segments and Product
11.3.2.3. Key Financials
11.3.2.4. Market Developments
11.3.2.5. Market Strategy
11.3.3. Medimetriks Pharmaceuticals, Inc.
11.3.3.1. Overview
11.3.3.2. Segments and Product
11.3.3.3. Key Financials
11.3.3.4. Market Developments
11.3.3.5. Market Strategy
11.3.4. Galderma
11.3.4.1. Overview
11.3.4.2. Segments and Product
11.3.4.3. Key Financials
11.3.4.4. Market Developments
11.3.4.5. Market Strategy
11.3.5. Johnson & Johnson
11.3.5.1. Overview
11.3.5.2. Segments and Product
11.3.5.3. Key Financials
11.3.5.4. Market Developments
11.3.5.5. Market Strategy
11.3.6. Novartis AG
11.3.6.1. Overview
11.3.6.2. Segments and Product
11.3.6.3. Key Financials
11.3.6.4. Market Developments
11.3.6.5. Market Strategy
11.3.7. Moberg Pharma AB
11.3.7.1. Overview
11.3.7.2. Segments and Product
11.3.7.3. Key Financials
11.3.7.4. Market Developments
11.3.7.5. Market Strategy
11.3.8. Cardinal Health, Inc.
11.3.8.1. Overview
11.3.8.2. Segments and Product
11.3.8.3. Key Financials
11.3.8.4. Market Developments
11.3.8.5. Market Strategy
11.3.9. Pfizer Inc.
11.3.9.1. Overview
11.3.9.2. Segments and Product
11.3.9.3. Key Financials
11.3.9.4. Market Developments
11.3.9.5. Market Strategy
11.3.10. Almirall, S.A.
11.3.10.1. Overview
11.3.10.2. Segments and Product
11.3.10.3. Key Financials
11.3.10.4. Market Developments
11.3.10.5. Market Strategy
11.3.11. Bayer AG
11.3.11.1. Overview
11.3.11.2. Segments and Product
11.3.11.3. Key Financials
11.3.11.4. Market Developments
11.3.11.5. Market Strategy
11.3.12. Viatris Inc.
11.3.12.1. Overview
11.3.12.2. Segments and Product
11.3.12.3. Key Financials
11.3.12.4. Market Developments
11.3.12.5. Market Strategy
11.3.13. GlaxoSmithKline plc
11.3.13.1. Overview
11.3.13.2. Segments and Product
11.3.13.3. Key Financials
11.3.13.4. Market Developments
11.3.13.5. Market Strategy
11.3.14. Cipla Ltd.
11.3.14.1. Overview
11.3.14.2. Segments and Product
11.3.14.3. Key Financials
11.3.14.4. Market Developments
11.3.14.5. Market Strategy
11.3.15. Dr. Reddy's Laboratories Ltd
11.3.15.1. Overview
11.3.15.2. Segments and Product
11.3.15.3. Key Financials
11.3.15.4. Market Developments
11.3.15.5. Market Strategy
12. Appendix
12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
